{
  "compound": "CBD for depression",
  "condition": "DEPRESSION",
  "effect_size": "N/A (guideline)",
  "study_type": "CLINICAL_GUIDELINE",
  "source": "NORML:DEPRESSION_GUIDELINE_001",
  "participants": "Guidelines based on systematic review and expert consensus (25 international experts)",
  "year": 2020,
  "notes": "Clinical Practice Guidelines for Cannabidiol Use in Depression: Evidence-Based Recommendations",
  "confidence": "medium",
  "abstract": "Strong recommendation (Grade A) for CBD in MDD when SSRIs inadequate; Moderate recommendation (Grade B) for first-line use in mild-moderate depression"
}